S. Shiraishi

发表

Glycated hemoglobin level on admission associated with progression to severe disease in hospitalized patients with non‐severe coronavirus disease 2019

M. Kurajoh, M. Emoto, T. Imai, 2022, Journal of diabetes investigation.

A phase I/II study comparing regimen schedules of gemcitabine and docetaxel in Japanese patients with stage IIIB/IV non-small cell lung cancer.

T. Mukohara, M. Fukuoka, S. Kudoh, 2005, Japanese journal of clinical oncology.

SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals

S. Fukumoto, Y. Matsuura, H. Nakagami, 2021, Scientific Reports.

SARS-CoV-2-induced humoral immunity through B cell epitope analysis and neutralizing activity in COVID-19 infected individuals in Japan

Y. Matsuura, H. Nakagami, C. Ono, 2020, bioRxiv.

Isoniazid-induced Immune Thrombocytopenia

M. Hino, H. Kakeya, T. Kawaguchi, 2021, Internal medicine.

Antibody Avidity Maturation Following Recovery From Infection or the Booster Vaccination Grants Breadth of SARS-CoV-2 Neutralizing Capacity

C. Watanabe, E. Adachi, H. Kunishima, 2022, The Journal of infectious diseases.

Antibody avidity maturation favors SARS-CoV-2 convalescents over vaccinated individuals granting breadth in neutralizability and tolerance against variants

E. Adachi, H. Kunishima, H. Kakeya, 2022, medRxiv.

Treatment and outcome of COVID-19 patients in a specialized hospital during the third wave: advance of age and increased mortality compared with the first/second waves

Y. Oda, O. Kurai, S. Shiraishi, 2021, JA Clinical Reports.

Clinical profiles and outcome of patients with COVID-19 in a specialized hospital in Japan

Y. Oda, O. Kurai, S. Shiraishi, 2021, Journal of Anesthesia.

COVID-19 vaccination benefits in preventing severe disease in mild-to-moderate cases: An analysis in the first specialized hospital for COVID-19 in Japan

H. Kakeya, T. Kawaguchi, K. Asai, 2023, Respiratory Investigation.